Literature DB >> 1742652

Improvement of symptoms of non-allergic chronic rhinitis by local treatment with capsaicin.

J S Lacroix1, J M Buvelot, B S Polla, J M Lundberg.   

Abstract

Sixteen adult patients suffering from severe chronic non-allergic rhinitis with nasal vasoconstrictor abuse for more than a year, received, under local anaesthesia, an intranasal spray of capsaicin (3.3 x 10(-3) mol), the pungent agent in hot pepper, once weekly for 5 weeks. The subjective intensity of their nasal obstruction, rhinorrhoea and sneezing frequency were evaluated throughout the study and the vascular effects of capsaicin on the nasal mucosa were recorded by anterior rhinomanometry and laser Doppler flowmetry. Calcitonin gene-related peptide (CGRP) is a vasodilator agent present in sensory nerves and may play a major role in the vascular component of neurogenic inflammation. Therefore, the nasal mucosa content of CGRP-like immunoreactivity (CGRP-LI) was determined by radioimmunoassay in biopsies obtained before and after the capsaicin treatment. Intra-nasal capsaicin application evoked a larger vascular response in patients with rhinitis than in controls (P less than 0.05). Both nasal vascular responses and subjective discomfort following capsaicin were markedly reduced after the fifth application (P less than 0.01). In parallel, a 50% reduction of the CGRP-LI content in the nasal biopsies was observed. All symptoms were significantly improved throughout a 6 month follow-up period. No significant side-effects occurred and weaning from nasal vasoconstrictor agents was possible. Both the subjective symptom score and objective measurements of vascular reactivity suggest that repeated intra-nasal capsaicin application could be beneficial for patients with chronic rhinitis, possibly by reducing hyperreactive nasal reflexes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1742652     DOI: 10.1111/j.1365-2222.1991.tb00852.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  18 in total

1.  Neurogenic inflammation in human airways: is it important?

Authors:  G F Joos; P R Germonpre; R A Pauwels
Journal:  Thorax       Date:  1995-03       Impact factor: 9.139

Review 2.  Capsaicin treatment of idiopathic rhinitis: the new panacea?

Authors:  Jeroen B van Rijswijk; Roy Gerth van Wijk
Journal:  Curr Allergy Asthma Rep       Date:  2006-03       Impact factor: 4.806

Review 3.  A role for capsaicin sensitive, tachykinin containing nerves in chronic coughing and sneezing but not in asthma: a hypothesis.

Authors:  J A Karlsson
Journal:  Thorax       Date:  1993-04       Impact factor: 9.139

4.  A randomized, double-blind, parallel trial comparing capsaicin nasal spray with placebo in subjects with a significant component of nonallergic rhinitis.

Authors:  Jonathan A Bernstein; Benjamin P Davis; Jillian K Picard; Jennifer P Cooper; Shu Zheng; Linda S Levin
Journal:  Ann Allergy Asthma Immunol       Date:  2011-06-29       Impact factor: 6.347

5.  Influence of TASP-V, a novel neuropeptide Y (NPY) Y2 agonist, on nasal and bronchial responses evoked by histamine in anaesthetized pigs and in humans.

Authors:  D D Malis; E Grouzmann; D R Morel; M Mutter; J S Lacroix
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

6.  Calcitonin gene-related peptide in vitro stimulation of ciliary beat in human upper respiratory cilia.

Authors:  P J Schuil; J G Rosmalen; K Graamans; E H Huizing
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

7.  Neutral endopeptidase activity and concentration of sensory neuropeptide in the human nasal mucosa.

Authors:  J S Lacroix; A M Kurt; N Pochon; C Bretton; J M Lundberg; J Deshusses
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

Review 8.  Nonallergic rhinitis.

Authors:  Phil Lieberman; Debendra Pattanaik
Journal:  Curr Allergy Asthma Rep       Date:  2014-06       Impact factor: 4.806

9.  Functional effects of phosphoramidon and captopril on exogenous neuropeptides in human nasal mucosa.

Authors:  C Châtelain; N Pochon; J S Lacroix
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

10.  Treatment of congestion in upper respiratory diseases.

Authors:  Eli O Meltzer; Fernan Caballero; Leonard M Fromer; John H Krouse; Glenis Scadding
Journal:  Int J Gen Med       Date:  2010-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.